Issue Highlights - March 2018

11/08/18 • -1 min

Clinical Gastroenterology and Hepatology Audio Summaries

New data suggest that urgent endoscopy within 6 hours may reduce mortality in selected high-risk patients with non-variceal upper GI bleeding. New decision-analytic model compares the effectiveness and cost-effectiveness of endoscopic therapy versus esophagectomy for T1a and T1b esophageal adenocarcinoma Diaphragmatic breathing reduces belching and PPI refractory gastroesophageal symptoms. Biliary sphincter of Oddidysfunction and suspected choledocholithias benefits from adoption of standardized practice algorithms for management of intermediate-risk patients to minimize unnecessary invasive testing.

Previous Episode

Issue Highlights - February 2018

Gluten-free diet may not be all that safe because of an increase in the accumulation of heavy metals. New study identifies optimal histologic cutoff for treatment of EoE. Researchers examine the benefits and risks of biologic treatment withdrawal in patients with Crohn's. New data shed light on the efficacy and limitations of budesonide as a second-line treatment for patients with autoimmune hepatitis.

Next Episode

Issue Highlights - April 2018

New data reinforce the perils of opiate use in IBD patients. Researchers find that non-CDI enteric infections are uncommon triggers of flares in IBD patients. Pioglitazone is effective for treating NASH in patients with or without diabetes. Hypothetical biomarker test with substantially better performance than FIT would be more cost-effective than FIT if its cost doesn't exceed $57.